Never has our understanding of biology and computation been evolving more rapidly. But what can these complex fields tell each other and how can they be integrated? For drug developers now is the time to harness this computing power to identify and to advance biologics candidates of superior affinity, stability and efficacy.

However, with the field in its infancy, there remains an ever-present need to address current capabilities amongst the scientific and operational challenges that exist when modelling complex biologics.

CDD for Biologics has been specifically designed to help biopharmaceutical companies define strategies to further adapt these tools, mitigate data availability issues and address computational-experimental challenges to add immediate value to their biologics pipelines.

Join a diverse faculty of experts from pharma, biotech, software developers and academia as we provide the platform to discuss what is needed to accelerate computational capability to the next level.